KFDA approved Yuyu new anti-osteoporosis drug, Maxmavil

Yuyu announced to get the KFDA approval for Maxmavil, a new combined anti-osteoporosis drug formulated with Alrendronate and Calcitriol on Nov. 16 and therefore to launched its sales around coming March next year.

Yuyu has succeeded in the development of Maxmavil with 7 year R&D investment and efforts, proving its excellent efficacy and safety. Yuyu estimated its sales at 10 billion won in t...